Ieq Capital LLC Has $1.95 Million Stock Position in Aflac Incorporated (NYSE:AFL)

Ieq Capital LLC lifted its holdings in shares of Aflac Incorporated (NYSE:AFLFree Report) by 0.5% during the 2nd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 21,775 shares of the financial services provider’s stock after purchasing an additional 101 shares during the quarter. Ieq Capital LLC’s holdings in Aflac were worth $1,945,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Brighton Jones LLC grew its stake in Aflac by 5.1% in the 2nd quarter. Brighton Jones LLC now owns 7,491 shares of the financial services provider’s stock valued at $669,000 after buying an additional 361 shares during the last quarter. XTX Topco Ltd acquired a new position in Aflac in the 2nd quarter valued at $1,686,000. Seven Eight Capital LP acquired a new position in Aflac in the 2nd quarter valued at $904,000. Beck Bode LLC grew its position in Aflac by 1.3% in the 2nd quarter. Beck Bode LLC now owns 143,350 shares of the financial services provider’s stock worth $12,803,000 after purchasing an additional 1,857 shares during the last quarter. Finally, Waterloo Capital L.P. acquired a new stake in Aflac in the 2nd quarter worth $211,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Aflac news, Director Thomas J. Kenny sold 2,000 shares of the business’s stock in a transaction dated Wednesday, August 7th. The shares were sold at an average price of $98.94, for a total value of $197,880.00. Following the completion of the transaction, the director now directly owns 18,158 shares of the company’s stock, valued at $1,796,552.52. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have issued reports on AFL. Morgan Stanley raised their price target on shares of Aflac from $91.00 to $98.00 and gave the stock an “equal weight” rating in a research report on Monday, August 19th. UBS Group raised their price target on shares of Aflac from $84.00 to $109.00 and gave the stock a “neutral” rating in a research report on Wednesday, August 14th. Piper Sandler raised their price target on shares of Aflac from $95.00 to $100.00 and gave the stock an “overweight” rating in a research report on Friday, June 28th. Jefferies Financial Group decreased their price target on shares of Aflac from $84.00 to $83.00 and set a “hold” rating on the stock in a research report on Friday, June 28th. Finally, Barclays started coverage on shares of Aflac in a report on Wednesday, September 4th. They set an “underweight” rating and a $96.00 price objective for the company. Three equities research analysts have rated the stock with a sell rating, nine have assigned a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, Aflac currently has a consensus rating of “Hold” and a consensus target price of $92.50.

Check Out Our Latest Stock Report on Aflac

Aflac Trading Up 0.0 %

Shares of AFL stock opened at $107.92 on Monday. Aflac Incorporated has a 12-month low of $74.89 and a 12-month high of $111.14. The company has a market capitalization of $61.32 billion, a P/E ratio of 11.91, a P/E/G ratio of 2.53 and a beta of 0.95. The firm has a 50-day moving average price of $102.88 and a 200 day moving average price of $92.03. The company has a quick ratio of 0.10, a current ratio of 0.10 and a debt-to-equity ratio of 0.29.

Aflac (NYSE:AFLGet Free Report) last announced its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.60 by $0.23. Aflac had a net margin of 28.35% and a return on equity of 16.22%. The firm had revenue of $5.14 billion during the quarter, compared to the consensus estimate of $4.10 billion. During the same period last year, the firm posted $1.58 EPS. The firm’s quarterly revenue was down .7% on a year-over-year basis. Research analysts forecast that Aflac Incorporated will post 6.75 earnings per share for the current fiscal year.

Aflac Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Monday, September 2nd. Shareholders of record on Wednesday, August 21st were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 1.85%. The ex-dividend date was Wednesday, August 21st. Aflac’s dividend payout ratio is presently 22.08%.

Aflac Profile

(Free Report)

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.

Recommended Stories

Institutional Ownership by Quarter for Aflac (NYSE:AFL)

Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.